{"name": "AqueSys",
 "permalink": "aquesys",
 "crunchbase_url": "http://www.crunchbase.com/company/aquesys",
 "homepage_url": "http://www.tif.net/portfolio_aquesys.htm",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "949.450.0250",
 "description": "",
 "created_at": "Mon Jul 05 02:04:21 UTC 2010",
 "updated_at": "Fri Jul 30 18:22:45 UTC 2010",
 "overview": "\u003Cp\u003EAqueSys is developing a proprietary surgical device for the treatment of glaucoma. Glaucoma is the second leading cause of blindness worldwide and affects up to 65 million individuals.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0009/2422/92422v1-max-150x150.png"],
     [[215,
       51],
      "assets/images/resized/0009/2422/92422v1-max-250x250.png"],
     [[215,
       51],
      "assets/images/resized/0009/2422/92422v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "David",
      "last_name": "Milne",
      "permalink": "david-milne",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-150x150.jpg"],
          [[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-250x250.jpg"],
          [[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/aquesys-inc-series-c-35m/",
    "source_description": "AqueSys, Inc.: Series C $35M",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Longitude Capital",
         "permalink": "longitude-capital",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/0126/60126v1-max-150x150.jpg"],
             [[237,
               64],
              "assets/images/resized/0006/0126/60126v1-max-250x250.jpg"],
             [[237,
               64],
              "assets/images/resized/0006/0126/60126v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Accuitive Medical Ventures",
         "permalink": "accuitive-medical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/9399/49399v2-max-150x150.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-250x250.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Carlyle Group",
         "permalink": "carlyle-group",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0002/3355/23355v1-max-150x150.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-250x250.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "9834 Research Drive",
    "address2": "Suite 100",
    "zip_code": "92618",
    "city": "Irvine",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}